LogicBio Therapeutics (LOGC) Misses Q4 EPS by 52c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +82.6%
Financial Fact:
Loss per share (in dollars per share): -0.01
Today's EPS Names:
UBAB, LOAN, FITB, More
EPS Growth %: +82.6%
Financial Fact:
Loss per share (in dollars per share): -0.01
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q4 EPS of ($0.52).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
- TXNM Energy and Blackstone extend merger deadline to May 2027
- Cadrenal Therapeutics CMO resigns, separation terms disclosed
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
